As of 2025-07-12, the Relative Valuation of Trillium Therapeutics Inc (TRIL.TO) is (4.46) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 23.33 CAD, the upside of Trillium Therapeutics Inc based on Relative Valuation is -119.1%.
The range of the Relative Valuation is (3.57) - (5.35) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.2x - 7.9x | 6.6x |
| Forward P/E multiples | 5.2x - 7.9x | 6.6x |
| Fair Price | (3.57) - (5.35) | (4.46) |
| Upside | -115.3% - -122.9% | -119.1% |
| Date | P/E |